Skip to main content

how did you guys pick your treatment center? what actually matters

Patient · · 42 views
So I'm at the point where I gotta make a call on where to do my follow-up stuff after the EPP surgery I had in February. I'm in Detroit and there's a couple places nearby but also some bigger names a few hours away and I'm trying to figure out what's actually worth the drive vs what's just reputation hype.

Like, everyone says go to the big cancer centers but nobody really explains what to actually look at. Is it just how many meso cases they do a year? I called Karmanos here in Detroit and they told me they do maybe 8-10 a year but they've got the surgeons on staff already. Then I called one of the bigger places downstate and they were quoting me like 40+ cases annually but it's two hours of driving each way and my wife would have to take even more time off.

I'm also wondering about stuff like do they have a pulmonologist and an oncologist who actually know meso specifically, or is it just general cancer docs? And what about the actual numbers like survival rates and recurrence rates. I tried asking one place for their stats and they kinda gave me the runaround, said it varies too much by stage and individual factors which is true but also didn't answer the question.

Anybody else have to make this choice? What questions did you wish you'd asked before you picked?

11 Replies

Family
I'm dealing with this exact thing right now from the other side, honestly. My dad had his EPP back in 2024 at Northwestern and we initially thought we'd do his follow-up oncology elsewhere because it seemed more convenient, but then we switched back to Northwestern for the chemotherapy protocols they were running. Best decision we made.

Here's what I'd actually look at beyond case volume: ask them point blank if they have a mesothelioma-specific tumor board. That's the thing nobody mentions but it matters so much. What that means is they have pulmonologists, thoracic surgeons, medical oncologists, and sometimes radiation oncology all meeting weekly to discuss cases together. Karmanos might do 8-10 cases but if those doctors are actually talking to each other about your dad's specific pathology and imaging every single week, that's worth more than a place seeing 40 cases where everyone's in different departments.

The survival rate question you asked is actually impossible for them to answer honestly because you're Stage IV now post-EPP which is not the same cohort as their overall stats. But what they CAN tell you is their median overall survival specifically for people who had EPP plus chemo, and if they won't or can't break it down that way, that's a red flag.

Drive matters but not as much as you think. We do the Northwestern drive from Chicago every three weeks for chemo and honestly it's become routine. My dad sleeps the whole way back.

What did they say when you asked about their chemotherapy regimens? Like are they doing pemetrexed and cisplatin or are they using newer protocols...
Medical Expert Response
The volume question is real but I'd push a little further on it. Case volume tells you how often they're seeing meso, but what I've found matters just as much is whether they have a dedicated multidisciplinary tumor board that meets specifically for thoracic malignancies. Not just a general oncology board where meso comes up once a quarter. There's actually a study from the IASLC published in 2019 looking at outcomes at mesothelioma reference centers versus community centers, and the difference in median survival was meaningful enough that the authors recommended formal designation criteria for specialized centers.

The runaround you got about survival stats is frustrating but honestly kind of expected. Centers that actually track their own outcomes rigorously tend to be more forthcoming, not less. If they couldn't give you anything at all, that's a data point.

And the pulmonologist piece you mentioned... that's something people don't ask about enough post-EPP. Your pulmonary function is going to look completely different now and you want someone who's seen that specific picture before, not someone approximating from general thoracic surgery patients.

Two hours is a lot to ask of your wife, I get that. But for follow-up imaging reads and treatment decisions specifically, the expertise gap between 8 cases a year and 40+ can show up in ways that are hard to see in the moment. Talk to your own oncologist about what your particular pathology warrants, because that changes the calculus a lot.
4 found this helpful
Patient
I'm wrestling with this same decision right now, honestly. I'm in Cleveland so I've got the Cleveland Clinic option which is obviously huge, but I'm also looking at a couple other places because my oncologist here keeps emphasizing that HIPEC expertise matters way more than general meso volume.

When I was doing my research back in November after diagnosis I found this paper from the Journal of Surgical Oncology that broke down peritoneal meso outcomes, and the centers that had dedicated cytoreduction plus HIPEC programs had noticeably different progression-free survival curves than places that just did the surgery part. So I started asking specifically about that. Does the surgeon do HIPEC themselves or do they have a separate perfusionist? How many HIPEC cases per year, not just meso cases total. That's what I'd ask.

The runaround you got is frustrating but honestly I got similar responses. What helped me was asking for their last five peritoneal meso patients' median overall survival. Not your case specifically, just the aggregate. If they can't give you that or won't, that's information too.

I also looked at whether they have someone who specializes in meso toxicity management because the side effects are specific. Like, a general oncologist might not know how to handle the peritoneal adhesions that can pop up months later. I called around in early December and kept detailed notes on who answered what, because after the third call you start forgetting who said what.

The drive factor is real though. I've got family stuff too and I'm trying to balance that against outcomes. Two hours each way adds up fast if you're doing follow-ups every six weeks or monthly. That's something worth modeling out before you commit.
Patient
Yeah the HIPEC thing is what I keep hearing too but nobody explains it right. So it sounds like your oncologist is saying the specific chemo expertise matters more than just "we see a lot of meso cases" which actually makes sense when you think about it, kinda like how a mechanic who specializes in transmissions is better than a general shop that does everything. Did your doc say which places around Cleveland actually have that dialed in, or are you still hunting for that info too?
Patient
I'm still in the decision phase myself so I haven't committed yet, but I've been doing exactly what you're doing right now. Called about five different centers in the past month and started keeping notes on what they actually tell you versus what they don't.

The case volume thing is real but it's not everything. I found a study from 2023 in the Journal of Thoracic Oncology that looked at peritoneal meso outcomes and honestly the difference between 8 cases a year and 40 wasn't as dramatic as you'd think once you controlled for stage at diagnosis. What mattered way more was whether they had someone doing HIPEC regularly. Like, are they doing it as part of a formal protocol or are they adapting it case by case? That's different.

For me the specific questions that actually got answers were: how many HIPEC procedures specifically did your team perform last year, not total meso cases. What's your median overall survival for stage 2 peritoneal meso diagnosed in the last three years. Do you have a dedicated meso team that meets weekly or is it general oncology. I also asked if they could connect me with another patient, not just give me statistics. One place in Columbus actually did that and talking to someone two years out was worth the awkward conversation honestly.

The runaround answer you got about "varies too much" is sort of legitimate but also a dodge. Every center should have their own data on their own patients. If they won't share it that tells you something.

I'm leaning toward trying for one of the larger academic centers even with the drive because the pulmonologist and meso-specific oncologist thing matters for the long game. But I'm not decided yet. Where are you leaning?
Patient
Yeah that's what I was hoping to hear, cause the drive thing is killing me. You got a link to that study or just the citation? I'm gonna bookmark it and maybe print it out to show my oncologist when we meet next week. The case volume thing had me all worked up but if the outcomes aren't that different then maybe staying local makes more sense, especially with everything else going on.
Medical Expert Response
This is such a real question and honestly one of the harder decisions you'll face in this whole process.

Volume does matter, but not the way most people think. The IASLC (International Association for the Study of Lung Cancer) has published data suggesting that outcomes for complex thoracic procedures correlate with institutional volume, but the cutoff isn't as high as people assume. The difference between 8 cases and 40 cases annually is less important than whether those 8 cases are being managed by a dedicated multidisciplinary team. What that means practically is a pulmonologist, a medical oncologist, and a thoracic surgeon who are actually talking to each other about your specific case, not just a general oncologist who happens to see the occasional meso patient.

The runaround you got about stats is frustrating but also... kind of honest? Mesothelioma outcomes vary so much by histology (cell type), stage at surgery, margin status after EPP, that center-level survival numbers can be genuinely misleading. What I'd ask instead is how many EPP patients they've managed post-operatively, and whether they have a formal meso tumor board that meets regularly.

The logistics piece is real too. I had a patient in 2019 who drove four hours to a major center for initial treatment, then transferred follow-up care to a regional program closer to home once the acute phase was done. That's actually a pretty common approach and worth asking both centers if they'd support a shared care arrangement.

Talk to your own oncologist about whether Karmanos's specific team has meso subspecialty focus, because that matters more than the raw case numbers.
4 found this helpful
Patient
Yeah that's really helpful actually, the part about volume not being as black and white as I thought. So you're saying 8 cases a year at Karmanos could actually be solid if they're doing it right, not just rubber stamping through cases? That kinda changes how I'm thinking about this whole thing. What would you say separates a place that's doing those 8 cases well from one that's just going through the motions?
Family
We went through this exact thing with Joe back in November when we were looking at where to do his immunotherapy. I'm gonna be honest, the volume thing matters but it's not everything. What ended up mattering more to us was whether the doctors actually talked to each other. Like, we'd go in for an appointment and the oncologist would know what the pulmonologist said the week before, and vice versa. That sounds basic but it's not everywhere.

We looked at places in Tampa and also up in Jacksonville, and when we called around I started asking "do you have someone who specializes in mesothelioma specifically or is this more of a general oncology team?" The bigger centers sometimes have a whole mesothelioma clinic with the same team seeing you every time. That continuity made a huge difference for us. Joe didn't have to re-explain his whole history every appointment.

The survival rate thing is tricky because yeah they're right that it varies, but a good center should at least be able to tell you their complication rates or their recurrence rates for your specific stage. We got that info from MD Anderson when we called them even though we didn't end up going there. One place literally could not give us anything concrete and that was a red flag. If they won't share their outcomes data, I'd keep looking.

One thing nobody tells you: ask about the support staff. Does the center have a social worker who knows mesothelioma? A patient navigator? We found out after we started that Joe's place has someone who helps with second opinions and clinical trials and honestly that person has been invaluable. The surgeon is important but so is the whole system around them.

How far along are you post-surgery? And are you looking at chemo, immunotherapy, or something else for follow-up?
Family
We went through this exact thing with Joe back in November when we were setting up his immunotherapy. I totally get the two hour drive question because that was our debate too, Tampa to MD Anderson versus staying local.

Here's what actually mattered to us. We asked about who specifically would be on Joe's care team, not just "we have oncologists" but like, who is the actual person seeing him every visit and do they have meso experience. When we called around, one place kept transferring us to different departments and another had a specific mesothelioma coordinator who answered on the second ring. That person ended up being invaluable because she knew all the clinical trials and could answer questions about side effects that general oncology nurses couldn't. So that's worth asking for by name if possible.

The survival rate thing... yeah they gave us the same runaround. What actually helped was asking about their approach to treatment, like do they do multimodal therapy or mostly chemo, and then looking up what the current literature says about outcomes with that approach. Kind of doing their homework for them in a way.

One thing nobody told us until we asked was about the team's continuity. Does the same doctor see your husband every time or does it rotate. Joe's been with the same oncologist since day one and that relationship has made everything easier, she knows his baseline and catches things faster.

The drive is real though. We do it and some weeks I'm exhausted just from the driving alone. But Joe says he'd rather have the right team than save two hours. Only you guys can decide what that tradeoff is worth... how often are they thinking he'd need to go in for treatment.
Veteran
Did my pleurectomy at Norfolk Naval Medical Center back in August, they had the team in house and knew what they were doing. Volume matters but so does having pulmonology right there when you need it, saves time.

Share Your Experience

Sign in or create a free account to share your experience.

Discussions in this community are for informational and emotional support purposes only. They do not constitute legal advice, medical advice, or an attorney-client relationship. Always consult a qualified professional for advice specific to your situation. Community Guidelines

Call Now: (800) 400-1805 Free Case Review • Available 24/7